VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GILDGilead Sciences, Inc.
$127.88$158.8B
Overview & Verdict
OverviewShould I Buy?
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksGILDQuarterly Financials

Gilead Sciences, Inc. (GILD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Gilead Sciences, Inc. (GILD) quarterly income statement — complete revenue, gross profit & net income history

GILD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue6.96B7.92B7.77B7.08B6.67B7.57B7.54B6.95B6.69B7.11B7.05B6.6B
Revenue Growth %4.39%4.69%2.97%1.84%-0.28%6.4%7.02%5.36%5.26%-3.72%0.11%5.42%
Cost of Goods Sold1.45B1.62B1.57B1.5B1.54B1.58B1.57B1.54B1.55B2.09B1.56B1.44B
COGS % of Revenue20.76%20.49%20.2%21.2%23.1%20.89%20.86%22.21%23.21%29.38%22.2%21.85%
Gross Profit5.51B6.3B6.2B5.58B5.13B5.99B5.97B5.41B5.13B5.02B5.49B5.16B
Gross Margin %79.24%79.51%79.8%78.8%76.9%79.11%79.14%77.79%76.79%70.62%77.8%78.15%
Gross Profit Growth %7.57%5.21%3.84%3.16%-0.14%19.19%8.86%4.89%3.7%-16.17%-2.87%7.04%
Operating Expenses2.93B3.31B2.87B3.11B2.89B3.54B5.08B2.77B9.46B3.41B2.86B3.49B
OpEx % of Revenue42.08%41.8%36.98%43.86%43.35%46.72%67.37%39.77%141.43%47.96%40.6%52.92%
Selling, General & Admin1.45B1.73B1.36B1.36B1.26B1.86B1.41B1.38B1.38B1.58B1.31B1.85B
SG&A % of Revenue20.85%21.81%17.47%19.28%18.87%24.59%18.69%19.8%20.57%22.21%18.65%28.02%
Research & Development1.37B1.58B1.35B1.49B1.38B1.64B1.4B1.35B1.52B1.41B1.46B1.41B
R&D % of Revenue19.71%19.99%17.33%21.06%20.68%21.68%18.49%19.43%22.73%19.79%20.67%21.32%
Other Operating Expenses1000K01000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income2.59B2.99B3.33B2.47B2.24B2.45B888M2.64B-4.32B1.61B2.62B1.67B
Operating Margin %37.16%37.71%42.82%34.94%33.55%32.4%11.77%38.03%-64.64%22.66%37.21%25.23%
Operating Income Growth %15.6%21.86%274.66%-6.43%151.76%52.11%-66.15%58.8%-353.49%-28.89%-7.54%-17.94%
EBITDA2.35B3.67B4.01B3.17B2.93B3.15B1.58B3.34B-3.63B2.3B3.31B2.35B
EBITDA Margin %33.78%46.38%51.65%44.7%43.99%41.55%20.91%48.01%-54.32%32.33%46.91%35.55%
EBITDA Growth %-19.84%16.85%154.31%-5.18%180.75%36.74%-52.28%42.28%-254.88%-17.71%-1.64%-8.14%
D&A (Non-Cash Add-back)0687M686M691M696M693M690M694M690M688M684M681M
EBIT2.35B2.33B3.9B2.68B1.91B2.42B1.19B2.29B-4.23B1.91B2.55B1.82B
Net Interest Income-240M-160M-168M-181M-166M-164M-186M-202M-146M-252M-126M-230M
Interest Income095M88M73M94M85M52M35M108M0106M0
Interest Expense240M255M256M254M260M249M238M237M254M252M232M230M
Other Income/Expense-6M-910M314M-45M-588M-285M68M-591M-164M41M-305M-77M
Pretax Income2.58B2.08B3.64B2.43B1.65B2.17B956M2.05B-4.49B1.65B2.32B1.59B
Pretax Margin %37.07%26.22%46.87%34.3%24.73%28.63%12.67%29.53%-67.1%23.24%32.88%24.06%
Income Tax559M-105M589M468M334M385M-297M438M-315M237M146M549M
Effective Tax Rate %21.67%-5.05%16.18%19.27%20.25%17.77%-31.07%21.33%7.02%14.34%6.3%34.57%
Net Income2.02B2.18B3.05B1.96B1.31B1.78B1.25B1.61B-4.17B1.43B2.18B1.04B
Net Margin %29.04%27.55%39.28%27.68%19.72%23.56%16.61%23.21%-62.37%20.09%30.92%15.84%
Net Income Growth %53.69%22.43%143.58%21.44%131.53%24.77%-42.52%54.45%-512.87%-12.87%21.86%-8.65%
Net Income (Continuing)2.02B2.18B3.05B1.96B1.31B1.78B1.25B1.61B-4.17B1.42B2.17B1.04B
Discontinued Operations000000000000
Minority Interest-84M0-84M-84M-84M-84M-84M-84M-84M-84M-72M-64M
EPS (Diluted)1.611.742.431.561.041.421.001.29-3.341.141.730.83
EPS Growth %54.81%22.54%143%20.93%131.14%24.56%-42.2%55.42%-517.5%-12.31%21.83%-8.79%
EPS (Basic)1.631.762.461.571.061.431.001.29-3.341.151.750.84
Diluted Shares Outstanding1.25B1.25B1.25B1.25B1.26B1.26B1.25B1.25B1.25B1.26B1.26B1.26B
Basic Shares Outstanding1.24B1.24B1.24B1.25B1.25B1.25B1.25B1.25B1.25B1.25B1.25B1.25B
Dividend Payout Ratio51.46%45.53%32.93%50.71%76.81%54.57%78.45%60.22%-65.99%43.72%90.33%